About the Bucks Formulary
This site is maintained by the formulary team of Buckinghamshire Healthcare NHS Trust in collaboration with NHS Buckinghamshire Medicines Management Team. Its prime objective is to update and ensure access to the Bucks Formulary which is linked to key local and national guidance and to the latest information on evidence based medicine via the NeLM link.
The site is designed to be used by healthcare professionals. It is assumed that the user will have the necessary knowledge, skill and competence to interpret the information presented, and where necessary to refer to specialist advice for clarification.
This site is dynamic and evolving. Feedback on suggestions for improvement may be emailed to FormularyTeam:
What is the Formulary?
This is a joint venture between secondary and primary care. Its aim is to promote safe, cost-effective prescribing across secondary and primary care (Buckinghamshire Healthcare NHS Trust and NHS Buckinghamshire). It is evidence-based, considers clinical efficacy and cost effectiveness and reflects the needs of the local population and local affordability.
The formulary is divided into sections reflecting the BNF. Alongside the medicines listed in each section are any relevant restrictions/advice/notes. This may include restrictions as to who may prescribe, first and second choices, references to clinical guidelines and more. In the near future links will be inserted to key local guidelines providing more information about place in therapy.
Who makes Formulary decisions?
Decisions about formulary choices, restrictions, traffic light position and key guidelines (including local adaptation of NICE recommendations) are made by the Formulary Management Group. This is a joint formulary committee and includes representation from hospital consultants, GPs, hospital and PCT pharmacists. It meets every two months and its decisions are endorsed by the Bucks Area Prescribing Committee (APC).
How should the Formulary be used?
It is recommended as a first "port of call" when making choices within a therapeutic group. The formulary is not designed to replace the BNF. All prescribers should continue to refer to the current edition of the BNF, supplemented as necessary from specialist publications and manufacturer's Summaries of Product Characteristics (SPC).
Unlicensed medicines / uses
The formulary includes some unlicensed products or uses of licensed products that fall outside of the SPC. These have been approved by the Formulary Management Group for use in specific clinical settings. They are clearly marked as unlicensed on the formulary together with their risk category (low, medium or high) Prescribers must take full responsibility for prescribing such products and comply with the GMC guidance and the Unlicensed Medicines Policy.
Drugs may be subject to several levels of restriction:-
- Prior named patient approval (eg. for high cost drugs)
NICE Compliance / High Cost Drugs - Consultants need to complete these forms (link) to confirm compliance with NICE criteria
- Defined consultants
- Defined specialties
- Defined indications
- Unrestricted prescribing in primary and secondary care
- Traffic light system categorisation across the health economy. (Please see link to Bucks traffic light system on right)
For formulary products used less commonly, there may be a delay before the product is available on site as stock may not be routinely kept.
Visits = 183332